NCT06647212

Brief Summary

The study aims to assess the effects of exercises using the harmonica on the exercise capacity, the level of depressive symptoms and disease related quality of life in patients suffering from heart disease attending cardiac rehabilitation program. The main questions it aims to answer are: Does harmonica exercise improve exercise capacity in patints with herat disease? Does harmonica exercise affect depression levels and health-related quality of life in patients with heart disease? Researchers will explore the effect of harmonica exercise on exercise capacity and selected psychological aspects of patients participating in cardiac rehabilitation program Participants will: Complete a cardiac rehabilitation program with assessment of exercise capacity at the beginning and end of the program Perform breathing exercises only or breathing exercises and harmonica exercises Keep a diary of their exercises

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 16, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 17, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

October 17, 2024

Status Verified

September 1, 2024

Enrollment Period

1 year

First QC Date

September 29, 2024

Last Update Submit

October 16, 2024

Conditions

Keywords

cardiac rehabilitationharmonica exercisesexercise capacityquality of lifedepression

Outcome Measures

Primary Outcomes (3)

  • exercise capacity

    Exercise capacity assessed by cardiopulmonary exercise testing measured by peak oxygen consumption.

    from enrollment to the end of cardiac rehabilitataion at 5 weeks

  • health related quality of life

    Health related quality of life measured by the EuroQOL five dimensions questionnaire.This is a self-reported description of the subject's current health in 5 dimensions i.e., mobility, self-care, usual activities, pain/discomfort and anxiety/depression

    from enrollment to the end of cardiac rehabilitataion program at 5 weeks

  • symptoms of depression

    Syptoms of depressin measured by Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively

    from enrollment to the end of cardiac rehabilitataion program at 5 weeks

Study Arms (2)

study arm

EXPERIMENTAL

patients randomized to the study arm will receive a breathing exercise program with standard diatonic mouth harmonica

Other: introducing breathing exercises with the harmonica

control arm

NO INTERVENTION

patients randomized to the control arm will follow standard cardiac rehabilitation program with breathing exercises only

Interventions

In addition to regular breathing exercises, participants will perform harmonica exercises

study arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients participating in cardiac rehabilitation program

You may not qualify if:

  • Decompensated heart failure, with symptoms in NYHA class II-IV within 3 weeks before admission to the Cardiac Rehabilitation Department
  • Poorly controlled hypertension (BP in office measurement \>160/100 mmHg)
  • Severe symptomatic heart disease (including valvular);
  • Other severe comorbidities, including those significantly limiting physical performance: chronic kidney disease with GFR \<30 ml/min/1.73m2 (according to the CKD-EPI formula), severe form of bronchial asthma/chronic obstructive pulmonary disease (stage C/D ), hypertrophic cardiomyopathy, significant cardiac arrhythmias (persistent/permanent atrial fibrillation, sustained supraventricular/ventricular tachycardia, multiple supraventricular/ventricular extrasystole \> 10,000/day), pulmonary embolism in the last 3 months, acute coronary syndrome in the last 7 days, peripheral arterial disease with claudication distance \<200 m, generalized active neoplastic process;
  • mental illness/dementia syndrome that prevents full cooperation with the examined person;
  • diseases of the musculoskeletal system that make it impossible to perform an exercise test;
  • contraindications to performing an exercise test;
  • contact allergy to the materials from which the body/cover of the harmonica is made, revealed during exercises
  • lack of consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiac Rehabilitation Department, Military Institute of Medicine National research Institute

Warsaw, 04-411, Poland

Location

MeSH Terms

Conditions

Coronary Artery DiseaseHeart FailureDepression

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesBehavioral SymptomsBehavior

Study Officials

  • Katarzyna Piotrowicz, MD, PhD, MS

    Military Institute of Medicine

    STUDY CHAIR
  • Anna Mierzyńska, PhD, MS

    Military Institute of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized, open study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Cardiac Rehabilitation Department

Study Record Dates

First Submitted

September 29, 2024

First Posted

October 17, 2024

Study Start

May 16, 2024

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

October 17, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations